Adverse outcomes · participants with progressive keratoconus
1 finding from 1 review
Intervention not reported
Adverse outcomes · People with lamellar macular holes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision (people with AMD)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · adults with low vision
The review found no eligible studies for this question.
1 finding from 1 review
Adverse outcomes · people with diabetic retinopathy
1 finding from 1 review
Adverse outcomes · People aged 50 years or older with age‐related macular degeneration
1 finding from 1 review
Intervention not reported
Adverse outcomes · People with HED who had corneal graft(s)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse outcomes · participants with idiopathic macular hole
Vitrectomy led to lower adverse outcomes compared with observation; GRADE not reported.
1 finding from 1 review
Adverse outcomes Up to 3 years · children at or before five years of age with primary congenital glaucoma
It is very uncertain whether combined trabeculotomy with trabeculectomy changes adverse outcomes Up to 3 years compared with trabeculotomy (very low certainty).
1 finding from 1 review
Adverse outcomes at any time point · people with BRVO
Anti‐VEGF probably leads to lower adverse outcomes at any time point compared with steroid (moderate certainty).
1 finding from 1 review
Adverse outcomes at any time point · macular oedema secondary to branch retinal vein occlusion
It is very uncertain whether anti‐VEGF changes adverse outcomes at any time point compared with sham (very low certainty).
1 finding from 1 review
Adverse outcomes at any time point · people with BRVO
It is very uncertain whether anti‐VEGF changes adverse outcomes at any time point compared with laser (very low certainty).
1 finding from 1 review
Adverse outcomes—corneal haze or scarring · participants with keratoconus
Transepithelial CXL probably leads to lower adverse outcomes—corneal haze or scarring compared with epithelium‐off CXL (moderate certainty).
1 finding from 1 review
Hyphema · children at or before five years of age with primary congenital glaucoma
Microcatheter‐assisted trabeculotomy probably leads to higher adverse outcomes— hyphema Up to 1 year after surgery compared with conventional trabeculotomy (moderate certainty).
1 finding from 1 review
Hyphema · children at or before five years of age with primary congenital glaucoma
Viscotrabeculotomy showed no clear difference in adverse outcomes—hyphema Up to 6 months after surgery compared with conventional trabeculotomy (low certainty).
1 finding from 1 review